The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024. Popular drugs like Escitalopram, Clonazepam, and Sertraline saw significant increases in sales. Greater awareness and virtual consultations contributed to this growth, with general physicians now also prescribing antidepressants.
